[Therapy of intestinal parasitoses].
D002590:Cestode Infections / Q000188:drug therapy; D006801:Humans; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy*; D008463:Mebendazole / Q000627:therapeutic use; D009349:Nematode Infections / Q000188:drug therapy; D009534:Niclosamide / Q000627:therapeutic use; D010303:Paromomycin / Q000627:therapeutic use; D011716:Pyrantel Pamoate / Q000627:therapeutic use; D011774:Pyrvinium Compounds / Q000627:therapeutic use; D013827:Thiabendazole / Q000627:therapeutic use
D011774:Pyrvinium Compounds; D010303:Paromomycin; D011716:Pyrantel Pamoate; D008463:Mebendazole; D009534:Niclosamide; D013827:Thiabendazole
Therapie der Darmparasitosen